Mamoru Yoshizawa

442 citations
10 papers · 193 indexed · h-index 7

Mamoru Yoshizawa

9 papers receiving 181 citations

Peers

Mamoru Yoshizawa
Comparison fields: 5 of 50
  • Nephrology 89
  • Cardiology and Cardiovascular Medicine 70
  • Endocrinology, Diabetes and Metabolism 35
  • Pathology and Forensic Medicine 26
  • Nutrition and Dietetics 20
Replace Keisuke Yatsu with:
Keisuke Yatsu Japan
Henrik Andersen Denmark
Jean‐Michel Poux France
Jitka Řehořová Czechia
Naïma Bellili-Muñoz France
Ji Gao China
B. M. Iversen Norway
Janette Mansour France
Nicolas Cornière France
K Higashi Japan
Mamoru Yoshizawa relative to Keisuke Yatsu Japan Keisuke Yatsu's profile →
Citations per field
00.5×1.7×
Keisuke Yatsu · 1×
Citations per year

Countries citing papers authored by Mamoru Yoshizawa

Since Specialization
Citations

This map shows the geographic impact of Mamoru Yoshizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Yoshizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Yoshizawa more than expected).

Fields of papers citing papers by Mamoru Yoshizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Yoshizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Yoshizawa. The network helps show where Mamoru Yoshizawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mamoru Yoshizawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mamoru Yoshizawa Line = papers co-authored together Mamoru Yoshizawa links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 20250
2 201710
3 20062
4 200576
5 200428
6 200027
7 19917
8 19877
9 19874
10 198432

About Mamoru Yoshizawa

Mamoru Yoshizawa is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 10 papers that have together received 193 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (4 papers), Pharmacological Effects and Toxicity Studies (2 papers), Electrolyte and hormonal disorders (2 papers), Asthma and respiratory diseases (2 papers), Mast cells and histamine (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Eosinophilic Esophagitis (1 paper). The work is most often cited by research in Nephrology (89 citations), Cardiology and Cardiovascular Medicine (70 citations) and Endocrinology, Diabetes and Metabolism (35 citations). Mamoru Yoshizawa has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Atsuhiro Ichihara, Koichiro Homma, Yuki Kaneshiro, Tomoko Takemitsu, Tomohiro Furukawa, Matsuhiko Hayashi, Takao Saruta, Tsuneo Takenaka, Yoshihiko Kanno and Jürgen C. Frölich. Their work appears in journals such as British Journal of Pharmacology, American Journal of Physiology-Endocrinology and Metabolism and American Journal of Kidney Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026